APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meropenem Powder Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Meropenem Powder Injection Industry Growth and Trends Forecast to 2032

27 December 2025102 pages

Choose your research edition.

Industry ResearchMeropenem Powder Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Meropenem Powder Injection Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Meropenem Powder Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meropenem Powder Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Meropenem Powder Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Meropenem Powder Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Meropenem Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Meropenem Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meropenem Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Meropenem Powder Injection include Chongqing Shenghuaxi Pharma, Haikou Pharmaceutical Factory, Luoxin Pharna, Hisun, Shanghai Pharma, United Laboratories, Sumitomo Pharma, PKU HealthCare and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Meropenem Powder Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Meropenem Powder Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Meropenem Powder Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Meropenem Powder Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Meropenem Powder Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Meropenem Powder Injection Market by Company

Chongqing Shenghuaxi Pharma

Haikou Pharmaceutical Factory

Luoxin Pharna

Hisun

Shanghai Pharma

United Laboratories

Sumitomo Pharma

PKU HealthCare

Pfizer

Joincare

Intelicure Lifesciences

CSPC Pharmaceutical Group

Meropenem Powder Injection Segment by Type

1.0g per Vial

0.50g per Vial

0.25g per Vial

Meropenem Powder Injection Segment by Application

Skin and Soft Tissue Infections（SSTI）

Meningitis

Urinary Tract Infection

Gynecological Infections

Septicemia

Other

Meropenem Powder Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meropenem Powder Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meropenem Powder Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meropenem Powder Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Meropenem Powder Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Meropenem Powder Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1.0g per Vial Table 2. Major Company of 0.50g per Vial Table 3. Major Company of 0.25g per Vial Table 4. Global Meropenem Powder Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Meropenem Powder Injection Sales by Type (2021-2026) & (K Units) Table 6. Global Meropenem Powder Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Meropenem Powder Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Meropenem Powder Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Meropenem Powder Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Meropenem Powder Injection Sales by Type (2027-2032) & (K Units) Table 11. Global Meropenem Powder Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Meropenem Powder Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Meropenem Powder Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Meropenem Powder Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Meropenem Powder Injection Sales by Type (2021-2026) & (K Units) Table 16. North America Meropenem Powder Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Meropenem Powder Injection Sales by Type (2021-2026) & (K Units) Table 18. Europe Meropenem Powder Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Meropenem Powder Injection Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Meropenem Powder Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Meropenem Powder Injection Sales by Type (2021-2026) & (K Units) Table 22. Latin America Meropenem Powder Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Meropenem Powder Injection Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Meropenem Powder Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Meropenem Powder Injection Industry Trends Table 26. Meropenem Powder Injection Industry Drivers Table 27. Meropenem Powder Injection Industry Opportunities and Challenges Table 28. Meropenem Powder Injection Industry Restraints Table 29. Global Meropenem Powder Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Meropenem Powder Injection Revenue Market Share by Company (2021-2026) Table 31. Global Meropenem Powder Injection Sales by Company (2021-2026) & (K Units) Table 32. Global Meropenem Powder Injection Sales Share by Company (2021-2026) Table 33. Global Meropenem Powder Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Meropenem Powder Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Meropenem Powder Injection Major Company Production Sites and Headquarters Table 36. Global Meropenem Powder Injection Company, Product Type & Application Table 37. Global Meropenem Powder Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Meropenem Powder Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Meropenem Powder Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Meropenem Powder Injection Sales by Region (2021-2026) & (K Units) Table 42. Global Meropenem Powder Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Meropenem Powder Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Meropenem Powder Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Meropenem Powder Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Meropenem Powder Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Meropenem Powder Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Meropenem Powder Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Meropenem Powder Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Meropenem Powder Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Meropenem Powder Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Meropenem Powder Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Meropenem Powder Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Meropenem Powder Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Meropenem Powder Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Meropenem Powder Injection Sales by Application (2027-2032) & (K Units) Table 58. Global Meropenem Powder Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Meropenem Powder Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Meropenem Powder Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Meropenem Powder Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Meropenem Powder Injection Sales by Application (2021-2026) & (K Units) Table 63. North America Meropenem Powder Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Meropenem Powder Injection Sales by Application (2021-2026) & (K Units) Table 65. Europe Meropenem Powder Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Meropenem Powder Injection Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Meropenem Powder Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Meropenem Powder Injection Sales by Application (2021-2026) & (K Units) Table 69. Latin America Meropenem Powder Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Meropenem Powder Injection Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Meropenem Powder Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Chongqing Shenghuaxi Pharma Company Information Table 73. Chongqing Shenghuaxi Pharma Business Overview Table 74. Chongqing Shenghuaxi Pharma Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Chongqing Shenghuaxi Pharma Meropenem Powder Injection Product Portfolio Table 76. Chongqing Shenghuaxi Pharma Recent Development Table 77. Haikou Pharmaceutical Factory Company Information Table 78. Haikou Pharmaceutical Factory Business Overview Table 79. Haikou Pharmaceutical Factory Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Haikou Pharmaceutical Factory Meropenem Powder Injection Product Portfolio Table 81. Haikou Pharmaceutical Factory Recent Development Table 82. Luoxin Pharna Company Information Table 83. Luoxin Pharna Business Overview Table 84. Luoxin Pharna Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Luoxin Pharna Meropenem Powder Injection Product Portfolio Table 86. Luoxin Pharna Recent Development Table 87. Hisun Company Information Table 88. Hisun Business Overview Table 89. Hisun Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Hisun Meropenem Powder Injection Product Portfolio Table 91. Hisun Recent Development Table 92. Shanghai Pharma Company Information Table 93. Shanghai Pharma Business Overview Table 94. Shanghai Pharma Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Shanghai Pharma Meropenem Powder Injection Product Portfolio Table 96. Shanghai Pharma Recent Development Table 97. United Laboratories Company Information Table 98. United Laboratories Business Overview Table 99. United Laboratories Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. United Laboratories Meropenem Powder Injection Product Portfolio Table 101. United Laboratories Recent Development Table 102. Sumitomo Pharma Company Information Table 103. Sumitomo Pharma Business Overview Table 104. Sumitomo Pharma Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Sumitomo Pharma Meropenem Powder Injection Product Portfolio Table 106. Sumitomo Pharma Recent Development Table 107. PKU HealthCare Company Information Table 108. PKU HealthCare Business Overview Table 109. PKU HealthCare Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. PKU HealthCare Meropenem Powder Injection Product Portfolio Table 111. PKU HealthCare Recent Development Table 112. Pfizer Company Information Table 113. Pfizer Business Overview Table 114. Pfizer Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Pfizer Meropenem Powder Injection Product Portfolio Table 116. Pfizer Recent Development Table 117. Joincare Company Information Table 118. Joincare Business Overview Table 119. Joincare Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Joincare Meropenem Powder Injection Product Portfolio Table 121. Joincare Recent Development Table 122. Intelicure Lifesciences Company Information Table 123. Intelicure Lifesciences Business Overview Table 124. Intelicure Lifesciences Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Intelicure Lifesciences Meropenem Powder Injection Product Portfolio Table 126. Intelicure Lifesciences Recent Development Table 127. CSPC Pharmaceutical Group Company Information Table 128. CSPC Pharmaceutical Group Business Overview Table 129. CSPC Pharmaceutical Group Meropenem Powder Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. CSPC Pharmaceutical Group Meropenem Powder Injection Product Portfolio Table 131. CSPC Pharmaceutical Group Recent Development Table 132. North America Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. North America Meropenem Powder Injection Sales by Country (2021-2026) & (K Units) Table 134. North America Meropenem Powder Injection Sales Market Share by Country (2021-2026) Table 135. North America Meropenem Powder Injection Sales Forecast by Country (2027-2032) & (K Units) Table 136. North America Meropenem Powder Injection Sales Market Share Forecast by Country (2027-2032) Table 137. North America Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Meropenem Powder Injection Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Meropenem Powder Injection Market Share by Country (2021-2026) Table 140. North America Meropenem Powder Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Meropenem Powder Injection Market Share Forecast by Country (2027-2032) Table 142. Europe Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Europe Meropenem Powder Injection Sales by Country (2021-2026) & (K Units) Table 144. Europe Meropenem Powder Injection Sales Market Share by Country (2021-2026) Table 145. Europe Meropenem Powder Injection Sales Forecast by Country (2027-2032) & (K Units) Table 146. Europe Meropenem Powder Injection Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Meropenem Powder Injection Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Meropenem Powder Injection Market Share by Country (2021-2026) Table 150. Europe Meropenem Powder Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Meropenem Powder Injection Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Meropenem Powder Injection Sales by Country (2021-2026) & (K Units) Table 154. Asia-Pacific Meropenem Powder Injection Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Meropenem Powder Injection Sales Forecast by Country (2027-2032) & (K Units) Table 156. Asia-Pacific Meropenem Powder Injection Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Meropenem Powder Injection Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Meropenem Powder Injection Market Share by Country (2021-2026) Table 160. Asia-Pacific Meropenem Powder Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Meropenem Powder Injection Market Share Forecast by Country (2027-2032) Table 162. Latin America Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Latin America Meropenem Powder Injection Sales by Country (2021-2026) & (K Units) Table 164. Latin America Meropenem Powder Injection Sales Market Share by Country (2021-2026) Table 165. Latin America Meropenem Powder Injection Sales Forecast by Country (2027-2032) & (K Units) Table 166. Latin America Meropenem Powder Injection Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Meropenem Powder Injection Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Meropenem Powder Injection Market Share by Country (2021-2026) Table 170. Latin America Meropenem Powder Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Meropenem Powder Injection Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Meropenem Powder Injection Sales by Country (2021-2026) & (K Units) Table 174. Middle East and Africa Meropenem Powder Injection Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Meropenem Powder Injection Sales Forecast by Country (2027-2032) & (K Units) Table 176. Middle East and Africa Meropenem Powder Injection Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Meropenem Powder Injection Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Meropenem Powder Injection Market Share by Country (2021-2026) Table 180. Middle East and Africa Meropenem Powder Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Meropenem Powder Injection Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Meropenem Powder Injection Distributors List Table 185. Meropenem Powder Injection Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Meropenem Powder Injection Image Figure 2. Global Meropenem Powder Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meropenem Powder Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Meropenem Powder Injection Sales (2021-2032) & (K Units) Figure 5. 1.0g per Vial Image Figure 6. Global 1.0g per Vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 0.50g per Vial Image Figure 8. Global 0.50g per Vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. 0.25g per Vial Image Figure 10. Global 0.25g per Vial Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Meropenem Powder Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Meropenem Powder Injection Market Share by Type 2025 VS 2032 Figure 13. North America Meropenem Powder Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Meropenem Powder Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Meropenem Powder Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Meropenem Powder Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Meropenem Powder Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Meropenem Powder Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Meropenem Powder Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Meropenem Powder Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Meropenem Powder Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Meropenem Powder Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Meropenem Powder Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Skin and Soft Tissue Infections（SSTI） Image Figure 26. Global Skin and Soft Tissue Infections（SSTI） Sales YoY Growth (2021-2032) & (K Units) Figure 27. Meningitis Image Figure 28. Global Meningitis Sales YoY Growth (2021-2032) & (K Units) Figure 29. Urinary Tract Infection Image Figure 30. Global Urinary Tract Infection Sales YoY Growth (2021-2032) & (K Units) Figure 31. Gynecological Infections Image Figure 32. Global Gynecological Infections Sales YoY Growth (2021-2032) & (K Units) Figure 33. Septicemia Image Figure 34. Global Septicemia Sales YoY Growth (2021-2032) & (K Units) Figure 35. Other Image Figure 36. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Meropenem Powder Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Meropenem Powder Injection Market Share by Application 2025 VS 2032 Figure 39. North America Meropenem Powder Injection Sales Market Share in Volume by Application in 2025 Figure 40. North America Meropenem Powder Injection Sales Market Share in Value by Application in 2025 Figure 41. Europe Meropenem Powder Injection Sales Market Share in Volume by Application in 2025 Figure 42. Europe Meropenem Powder Injection Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Meropenem Powder Injection Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Meropenem Powder Injection Sales Market Share in Value by Application in 2025 Figure 45. Latin America Meropenem Powder Injection Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Meropenem Powder Injection Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Meropenem Powder Injection Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Meropenem Powder Injection Sales Market Share in Value by Application in 2025 Figure 49. North America Meropenem Powder Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Meropenem Powder Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Meropenem Powder Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Meropenem Powder Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Meropenem Powder Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Meropenem Powder Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Meropenem Powder Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Meropenem Powder Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Meropenem Powder Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Meropenem Powder Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Meropenem Powder Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Meropenem Powder Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Meropenem Powder Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Meropenem Powder Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Meropenem Powder Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Meropenem Powder Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Meropenem Powder Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Meropenem Powder Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Meropenem Powder Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Meropenem Powder Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Meropenem Powder Injection Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Meropenem Powder Injection Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • 1.0g per Vial
  • 0.50g per Vial
  • 0.25g per Vial
Applications
  • Skin and Soft Tissue Infections（SSTI）
  • Meningitis
  • Urinary Tract Infection
  • Gynecological Infections
  • Septicemia
  • Other
Companies covered
  • Chongqing Shenghuaxi Pharma
  • Haikou Pharmaceutical Factory
  • Luoxin Pharna
  • Hisun
  • Shanghai Pharma
  • United Laboratories
  • Sumitomo Pharma
  • PKU HealthCare
  • Pfizer
  • Joincare
  • Intelicure Lifesciences
  • CSPC Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Meropenem Powder Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Meropenem Powder Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Meropenem Powder Injection Market by Type
  6. 1.3.1 1.0g per Vial
  7. 1.3.2 0.50g per Vial
  8. 1.3.3 0.25g per Vial
  9. 1.4 Global Meropenem Powder Injection Market Size by Type
  10. 1.4.1 Global Meropenem Powder Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Meropenem Powder Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Meropenem Powder Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Meropenem Powder Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Meropenem Powder Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Meropenem Powder Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Meropenem Powder Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Meropenem Powder Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Meropenem Powder Injection Industry Trends
  2. 2.2 Meropenem Powder Injection Industry Drivers
  3. 2.3 Meropenem Powder Injection Industry Opportunities and Challenges
  4. 2.4 Meropenem Powder Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Meropenem Powder Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Meropenem Powder Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Meropenem Powder Injection Price (2021-2026)
  4. 3.4 Global Meropenem Powder Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Meropenem Powder Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Meropenem Powder Injection Company, Product Type & Application
  7. 3.7 Global Meropenem Powder Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Meropenem Powder Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Meropenem Powder Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Meropenem Powder Injection Tier 1, Tier 2, and Tier 3
4 Meropenem Powder Injection Regional Status and Outlook
  1. 4.1 Global Meropenem Powder Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Meropenem Powder Injection Historic Market Size by Region
  3. 4.2.1 Global Meropenem Powder Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Meropenem Powder Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Meropenem Powder Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Meropenem Powder Injection Forecasted Market Size by Region
  7. 4.3.1 Global Meropenem Powder Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Meropenem Powder Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Meropenem Powder Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Meropenem Powder Injection by Application
  1. 5.1 Meropenem Powder Injection Market by Application
  2. 5.1.1 Skin and Soft Tissue Infections（SSTI）
  3. 5.1.2 Meningitis
  4. 5.1.3 Urinary Tract Infection
  5. 5.1.4 Gynecological Infections
  6. 5.1.5 Septicemia
  7. 5.1.6 Other
  8. 5.2 Global Meropenem Powder Injection Market Size by Application
  9. 5.2.1 Global Meropenem Powder Injection Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Meropenem Powder Injection Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Meropenem Powder Injection Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Meropenem Powder Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Meropenem Powder Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Meropenem Powder Injection Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Meropenem Powder Injection Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Meropenem Powder Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Shenghuaxi Pharma
  2. 6.1.1 Chongqing Shenghuaxi Pharma Company Information
  3. 6.1.2 Chongqing Shenghuaxi Pharma Business Overview
  4. 6.1.3 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Product Portfolio
  6. 6.1.5 Chongqing Shenghuaxi Pharma Recent Developments
  7. 6.2 Haikou Pharmaceutical Factory
  8. 6.2.1 Haikou Pharmaceutical Factory Company Information
  9. 6.2.2 Haikou Pharmaceutical Factory Business Overview
  10. 6.2.3 Haikou Pharmaceutical Factory Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Haikou Pharmaceutical Factory Meropenem Powder Injection Product Portfolio
  12. 6.2.5 Haikou Pharmaceutical Factory Recent Developments
  13. 6.3 Luoxin Pharna
  14. 6.3.1 Luoxin Pharna Company Information
  15. 6.3.2 Luoxin Pharna Business Overview
  16. 6.3.3 Luoxin Pharna Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Luoxin Pharna Meropenem Powder Injection Product Portfolio
  18. 6.3.5 Luoxin Pharna Recent Developments
  19. 6.4 Hisun
  20. 6.4.1 Hisun Company Information
  21. 6.4.2 Hisun Business Overview
  22. 6.4.3 Hisun Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hisun Meropenem Powder Injection Product Portfolio
  24. 6.4.5 Hisun Recent Developments
  25. 6.5 Shanghai Pharma
  26. 6.5.1 Shanghai Pharma Company Information
  27. 6.5.2 Shanghai Pharma Business Overview
  28. 6.5.3 Shanghai Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai Pharma Meropenem Powder Injection Product Portfolio
  30. 6.5.5 Shanghai Pharma Recent Developments
  31. 6.6 United Laboratories
  32. 6.6.1 United Laboratories Company Information
  33. 6.6.2 United Laboratories Business Overview
  34. 6.6.3 United Laboratories Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 United Laboratories Meropenem Powder Injection Product Portfolio
  36. 6.6.5 United Laboratories Recent Developments
  37. 6.7 Sumitomo Pharma
  38. 6.7.1 Sumitomo Pharma Company Information
  39. 6.7.2 Sumitomo Pharma Business Overview
  40. 6.7.3 Sumitomo Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sumitomo Pharma Meropenem Powder Injection Product Portfolio
  42. 6.7.5 Sumitomo Pharma Recent Developments
  43. 6.8 PKU HealthCare
  44. 6.8.1 PKU HealthCare Company Information
  45. 6.8.2 PKU HealthCare Business Overview
  46. 6.8.3 PKU HealthCare Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 PKU HealthCare Meropenem Powder Injection Product Portfolio
  48. 6.8.5 PKU HealthCare Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Meropenem Powder Injection Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Joincare
  56. 6.10.1 Joincare Company Information
  57. 6.10.2 Joincare Business Overview
  58. 6.10.3 Joincare Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Joincare Meropenem Powder Injection Product Portfolio
  60. 6.10.5 Joincare Recent Developments
  61. 6.11 Intelicure Lifesciences
  62. 6.11.1 Intelicure Lifesciences Company Information
  63. 6.11.2 Intelicure Lifesciences Business Overview
  64. 6.11.3 Intelicure Lifesciences Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Intelicure Lifesciences Meropenem Powder Injection Product Portfolio
  66. 6.11.5 Intelicure Lifesciences Recent Developments
  67. 6.12 CSPC Pharmaceutical Group
  68. 6.12.1 CSPC Pharmaceutical Group Company Information
  69. 6.12.2 CSPC Pharmaceutical Group Business Overview
  70. 6.12.3 CSPC Pharmaceutical Group Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CSPC Pharmaceutical Group Meropenem Powder Injection Product Portfolio
  72. 6.12.5 CSPC Pharmaceutical Group Recent Developments
7 North America by Country
  1. 7.1 North America Meropenem Powder Injection Sales by Country
  2. 7.1.1 North America Meropenem Powder Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Meropenem Powder Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Meropenem Powder Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Meropenem Powder Injection Market Size by Country
  6. 7.2.1 North America Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Meropenem Powder Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Meropenem Powder Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Meropenem Powder Injection Sales by Country
  2. 8.1.1 Europe Meropenem Powder Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Meropenem Powder Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Meropenem Powder Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Meropenem Powder Injection Market Size by Country
  6. 8.2.1 Europe Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Meropenem Powder Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Meropenem Powder Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Meropenem Powder Injection Sales by Country
  2. 9.1.1 Asia-Pacific Meropenem Powder Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Meropenem Powder Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Meropenem Powder Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Meropenem Powder Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Meropenem Powder Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Meropenem Powder Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Meropenem Powder Injection Sales by Country
  2. 10.1.1 South America Meropenem Powder Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Meropenem Powder Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Meropenem Powder Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Meropenem Powder Injection Market Size by Country
  6. 10.2.1 South America Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Meropenem Powder Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Meropenem Powder Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Meropenem Powder Injection Sales by Country
  2. 11.1.1 Middle East and Africa Meropenem Powder Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Meropenem Powder Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Meropenem Powder Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Meropenem Powder Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Meropenem Powder Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Meropenem Powder Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Meropenem Powder Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Meropenem Powder Injection Value Chain Analysis
  2. 12.1.1 Meropenem Powder Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Meropenem Powder Injection Production Mode & Process
  7. 12.2 Meropenem Powder Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Meropenem Powder Injection Distributors
  10. 12.2.3 Meropenem Powder Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst